While stimulating the subthalamic nucleus (STN) generally has been the therapy of choice, new research published in the June 20, 2012, issue of Neurology®, the medical journal of the American Academy of Neurology, challenges that preferred status, finding that stimulating the internal globus pallidus (GPi) may provide some long-term advantages.
The subthalamic nucleus has been regarded as the preferred target since 2002, when the Food and Drug Administration approved the therapy for Parkinson’s disease. Many physicians made this therapeutic choice because stimulation of the subthalamic nucleus often enabled patients to reduce their drugs, such as levodopa; the choice of target was left to doctors because no major clinical trial had shown that one target provides better results than the other.
The largest randomized trial, published in 2010, found “motor” outcomes – movement control – fared equally, regardless of target. That study and others also showed that while stimulation can improve motor skills, it does not stop cognitive, mood or behavioral declines.
The new study, based on outcomes in 159 patients from the 2010 trial, challenges the preferred targeting, finding that stimulating the internal globus pallidus may provide long-term advantages in both motor skills and cognitive function.
In his editorial, Tagliati says these and other findings warrant more research to answer questions such as: “Is it important or even desirable to reduce medications over the long term? Do medication and stimulation have a complementary or alternative role? Is GPi stimulation more compatible with long-term medical therapy? Is chronic STN stimulation interfering with dopaminergic stimulation?”
“If the art of making medical decisions reflects a continuous struggle between evidence- and preference-based practices, this study will inject more reliable evidence in delicate long-term decisions, based until now almost exclusively on the preference and personal experience of the DBS provider,” he concludes.
Citation: Neurology: “Turning Tables: Should GPi become the preferred DBS target for Parkinson’s Disease?” (editorial), published online at 4 p.m. Eastern time June 20, 2012, in print July 3, 2012.Media Contact: Sandy Van
Sandy Van | Cedars-Sinai News
The healing effect of radon
23.01.2019 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Energizing the immune system to eat cancer
22.01.2019 | University of Pennsylvania School of Medicine
So-called bifacial stem cells are responsible for one of the most critical growth processes on Earth – the formation of wood.
Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer...
The scientific and political community alike stress the importance of German Antarctic research
Joint Press Release from the BMBF and AWI
The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...
World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles
The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.
Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.
In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...
16.01.2019 | Event News
14.01.2019 | Event News
12.12.2018 | Event News
23.01.2019 | Materials Sciences
23.01.2019 | Life Sciences
23.01.2019 | Life Sciences